Entering text into the input field will update the search result below

Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2020 Earnings Conference Call March 1, 2021 8:30 AM ET

Company Participants

Andrew Faughnan - Head, IR

John Crowley - Chairman & CEO

Bradley Campbell - President & COO

Jeff Castelli - CDO

Daphne Quimi - CFO

Hung Do - Chief Science Officer

Mitchell Goldman - SVP, Clinical Research

Conference Call Participants

Tazeen Ahmad - Bank of America

Irina Margine - Cowen

Tessa Romero - JP Morgan

Mohit Bansal - Citigroup

Kristen Kluska - Cantor Fitzgerald

Aaron Welch - Guggenheim Securities


Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Fourth Quarter 2020 Fiscal Year Results Conference Call and Webcast. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Head of Investor Relations. You may begin.

Andrew Faughnan

Good morning. Thank you for joining our conference call to discuss Amicus Therapeutics' full-year 2020 financial results and corporate highlights.

Speaking on today's call, we have John Crowley, Chairman and Chief Executive Officer; Bradley Campbell, President and Chief Operating Officer; Daphne Quimi, Chief Financial Officer; and Dr. Jeff Castelli, Chief Development Officer. Joining for Q&A, we’ll have Dr. Hung Do, Chief Science Officer and Dr. Mitchell Goldman, Senior Vice President of Clinical Research.

As referenced on Slide 2, we may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our business, as well as our plans and prospects. Our forward-looking statements should not be regarded as representation by us that any of our plans will be achieved. Any or all of the forward-looking statements made on this call may turn out

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About FOLD

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on FOLD

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.